Systematic review and meta‐analysis: Safety of vedolizumab during pregnancy in patients with inflammatory bowel disease

Volume: 36, Issue: 10, Pages: 2640 - 2648
Published: Jun 22, 2021
Abstract
Vedolizumab is a novel monoclonal antibody used in patients with inflammatory bowel disease, often affecting women of child-bearing age. We aimed to compare maternal and fetal adverse outcomes in pregnancies of women with inflammatory bowel disease exposed to vedolizumab versus those on other treatment.We performed a systematic literature search through December 2020 looking for studies including outcomes from pregnancies of female inflammatory...
Paper Details
Title
Systematic review and meta‐analysis: Safety of vedolizumab during pregnancy in patients with inflammatory bowel disease
Published Date
Jun 22, 2021
Volume
36
Issue
10
Pages
2640 - 2648
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.